Intravitreal Aflibercept in Patients With Retinal Pigment Epithelial Detachment (PED) Secondary to Age Related Macular Degeneration (AMD)
Phase of Trial: Phase IV
Latest Information Update: 13 Aug 2018
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 03 Aug 2018 Status changed from active, no longer recruiting to completed.
- 01 Aug 2018 Planned End Date changed from 1 May 2018 to 1 Apr 2019.
- 19 Dec 2017 New trial record